Page 3 - Stat Facts News Today

Company Announcement Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival at predetermined, independent interim analysisTrial results to be submitted for...

Seagen Inc. and Genmab A/S announced today that the Phase 3 innovaTV 301 global trial in recurrent or metastatic cervical cancer patients with disease progression on or after front-line therapy who...

An epidemic of sexually transmitted HPV is now swirling around the US and the UK. Some serious cases have led to oropharyngeal cancer, which can affect the back of the throat, tonsils, and tongue.

New magnetic tech allows physicians to perform guided endoscopy to detect gastric illnesses much earlier.

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for...

L’AFP est une agence d’information globale, assurant une couverture rapide, complète et vérifiée des événements de l’actualité comme des thèmes qui façonnent notre quotidien. Avec un réseau de journalistes sans égal, déployé sur 151 pays, l'AFP est en outre un leader mondial de l’investigation nu...

Investegate announcements from AstraZeneca PLC, Enhertu approved in EU for gastric cancer

Four oral presentations presented at ASH highlight data evaluating investigational epcoritamab for the treatment of relapsed/refractory (R/R) foll...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Epcoritamab featured in multiple data disclosures, including four oral presentationsResults presented from the phase 1b/2 EPCORE™ NHL-2 trial of epcoritamab combined with standard salvage therapy in patients with transplant eligible relapsed/refractory (R/R) diffuse large B-cell...

Epcoritamab featured in multiple data disclosures, including four oral presentations Results presented from the phase 1b/2 EPCORE NHL-2 trial of epcoritamab combined with standard salvage